Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Anaphylactic response to topical fluorescein 2% eye drops: a case repor | Shahid and Salmon Journal of Medical Case Reports 2010 4 27 http content 4 1 27 jAg JOURNALOF medical ÌỤr case REPORTS CASE REPORT Open Access Anaphylactic response to topical fluorescein 2 eye drops a case report Humma Shahid John F Salmon Abstract Introduction The intravenous use of fluorescein 10 during retinal angiography can cause severe systemic reactions including on rare occasions anaphylaxis. Fluorescein 2 eye drops are used extensively for clinical examination and diagnosis but to the best of our knowledge they have only been reported as being responsible for a systemic anaphylactic response on two previous occasions. Case presentation We report the case of a 51-year-old woman who developed an anaphylactic reaction when she was administered fluorescein sodium 2 eye drops after cataract surgery. This was the second time she had been exposed to fluorescein. She had brittle asthma and a history of anaphylaxis following exposure to a variety of drug and food allergens. She was successfully resuscitated and recovered completely over a period of two days. Conclusions Fluorescein 2 drops are universally used in general practice ophthalmology optometry and casualty departments. Our case report reveals the potential for this benign eye drop to cause a life-threatening systemic reaction and emphasises the importance of considering this consequence when administering topical fluorescein 2 to a patient with a history of anaphylaxis to other allergens. Introduction The most common cause of a life-threatening medical emergency in outpatient ophthalmology clinics is the administration of intravenous fluorescein 10 during retinal angiographic investigations. Most of the side effects of intravenous fluorescein are relatively benign and the most common reactions are nausea vomiting and a combination of flushing itching or urticaria 1 . The frequency of severe reactions to intravenous fluorescein administration including laryngeal .
